Horizon Trial, 2 Simcoe Street S, Oshawa, ON (2026)

02/25/2026

Finding clinical trials that are recruiting cancer patients in Canada can be a critical step for many individuals seeking new treatment options or contributing to research. Clinical trials test emerging therapies, targeted treatments and novel approaches that may not yet be widely available outside research settings. Knowing where to look and how to navigate the process helps patients and families access these opportunities with confidence.

A foundational place to start is with official registries. National and international databases list trials that are actively recruiting, with details on eligibility criteria, location and contact information. These registries allow users to search by condition, location and phase of the study so they can find trials that fit specific needs.

Healthcare teams, especially oncology specialists and nurses, are another valuable resource. They often know about local trials, upcoming studies or research collaborations that may not be immediately obvious through public searches. Speaking directly with a care provider can help patients understand how a trial aligns with their treatment goals and overall health plan.

Hospitals, academic research centres and cancer clinics frequently host clinical trials. These institutions often have dedicated research departments or trial coordinators who can provide trial lists, answer questions and guide patients through preliminary steps.

Patient support networks, advocacy groups and community organizations can also help. These groups regularly share information about available trials, offer peer support and sometimes connect patients with navigators who specialize in research access.

Understanding the options for finding clinical trials helps individuals take an informed approach to exploring available opportunities, including those focused on cancer treatments. It empowers patients to engage with research that may make a meaningful difference in their care journey.

02/21/2026

🤖 Finding a clinical trial should not feel like searching blind. But for many patients, it still does.

For years, matching patients to clinical trials meant digging through long listings, confusing eligibility criteria, and dead ends that led nowhere. Many people never found trials they actually qualified for, simply because the process was too slow, too manual, or too hard to navigate.

That is starting to change. Artificial intelligence is quietly reshaping how patients are matched to clinical trials by reading medical records more intelligently, understanding eligibility criteria in context, and connecting people to relevant studies faster than traditional methods ever could.

This shift matters. Timing can affect treatment options, quality of life, and outcomes. AI-powered matching helps reduce wasted time, lowers the chance of being screened out later, and surfaces trials patients might never have discovered on their own. Instead of broad keyword searches, patients can see studies that actually fit their diagnosis, treatment history, and current health status.

At the same time, AI is not magic. It depends on good data, strong privacy protections, and informed decisions made with a medical team. This blog explains what AI trial matching really does, where it helps most, where its limits are, and what patients should look for when using these tools.

If you are exploring clinical trials and feeling overwhelmed by the process, understanding how this technology works can help you approach your options with more clarity and confidence.

👇 Read the full blog to learn how AI is changing patient matching in clinical trials. Link in the comments.

02/18/2026

Artificial intelligence is reshaping how clinical trial recruitment works, making the process faster, smarter and more inclusive. Identifying eligible participants has long been a challenge in research. Traditional methods can be slow, manual and difficult to scale, which can delay studies and limit opportunities for both patients and researchers.

AI changes the game by examining large volumes of health data, medical records and eligibility criteria, and then matching potential candidates with trials more efficiently than manual review alone. Instead of sorting through paperwork or searching lists by hand, AI-driven systems can scan thousands of records quickly and highlight individuals who meet complex requirements. This speeds up recruitment timelines and takes pressure off clinical staff.

Another key advantage is that AI can help broaden participant diversity. Traditional recruitment processes sometimes overlook populations that are harder to reach, which can affect the quality and generalizability of research results. By analyzing patterns and removing bias from initial screening, AI tools can help identify candidates from a wider range of demographics and health backgrounds, supporting more representative study populations.

AI tools also reduce the screening burden on both patients and trial teams by pre-validating eligibility before formal assessments begin. This saves time, reduces unnecessary clinic visits and helps trials maintain momentum from start to finish. Predictive matching mechanisms help ensure that individuals who are likely to benefit from a study are connected with appropriate opportunities sooner.

As the clinical trial landscape becomes more complex, AI will continue to play a leading role in how participants are found, engaged and enrolled. Its adoption helps studies run more efficiently, makes opportunities more visible and supports research that is more inclusive and evidence driven.

02/14/2026

When patients ask about clinical trials, doctors must weigh several important factors before making a recommendation. Clinical trials can offer access to cutting edge therapies, but they are not always the right choice for every person. Doctors start by evaluating a patient’s overall health and how well current treatments are working. If a patient is responding well and maintaining quality of life with standard care, a doctor may decide that continuing that treatment is in the patient’s best interest.

Matching eligibility criteria is another major consideration. Clinical trials have specific requirements regarding age, disease stage, prior treatments and other medical conditions. Even if a trial exists for a condition, a patient may not meet the criteria, which means the doctor cannot safely recommend that option. Doctors must also consider potential risks. Because trials involve treatments or approaches that are still being evaluated, the long term effectiveness may be unknown and side effects can occur. Physicians carefully assess whether the potential benefits outweigh these uncertainties.

Patient preferences play an important role as well. Some patients want to pursue every possible treatment avenue, while others prefer to stay with familiar care and routines. A doctor listens to concerns, expectations and lifestyle factors to determine if a trial fits a person’s goals and capacity for additional clinic visits and procedures.

In some cases, trials may be available but not recommended because they are not convenient, not offered nearby, or do not improve outcomes compared with the patient’s current plan. When doctors do not recommend a clinical trial, it is usually because they are prioritizing safety, quality of care and the most appropriate evidence-based treatment path.

Understanding how these decisions are made helps patients and families engage in thoughtful conversations with their care team and make informed choices together.

02/11/2026

🧠 Phase 1, Phase 2, Phase 3. But which clinical trial phase actually makes sense for you?

When patients and families start exploring clinical trials, the phase numbers can feel confusing and overwhelming. Most explanations describe what each phase is, but very few explain how those phases connect to real patient decisions. This guide was written to close that gap.

Clinical trials are not one-size-fits-all. The right phase depends on where you are in your treatment journey, how much uncertainty you are comfortable with, and what your goals are right now. A Phase 1 trial may make sense for someone who has exhausted standard options and is open to early-stage research. Phase 2 may appeal to patients looking for treatments that have passed initial safety testing but are still being evaluated for effectiveness. Phase 3 often feels more familiar, comparing a new treatment directly against current standard care with much more data behind it.

Understanding these differences is not just academic. It affects risk, monitoring, time commitment, and expectations. Knowing what each phase truly involves helps you have clearer, more grounded conversations with your medical team and ask the right questions before enrolling.

This blog breaks down each phase from a patient perspective, explains who typically joins each one, and outlines the real trade-offs patients and families should think about before deciding.

👇 Read the full blog to understand which clinical trial phase may be right for you. Link in the comments.

02/08/2026

Many people assume they do not qualify for clinical trials without fully understanding how eligibility works. Clinical trial eligibility criteria are rules set by researchers that determine who can participate. These criteria exist to protect participants and to make sure the study results are meaningful and reliable. Researchers carefully define what they are looking for in participants so the trial can answer the scientific questions it was designed to study.

Eligibility criteria typically include factors such as age, specific disease or condition stage, treatment history, and sometimes genetic or biomarker requirements. These characteristics form the inclusion criteria, which are the traits a person must have to be considered for a study.

On the other hand, exclusion criteria are reasons why someone might be disqualified from participating, even if they meet some of the inclusion points. Common disqualifiers include other serious medical conditions that could interfere with the study’s safety or data, the use of medications that conflict with the trial protocol, or functional health limitations that pose risk during the study. Even lifestyle factors or the inability to commit to required visits can play a role in eligibility.

Because these criteria vary widely between trials, not qualifying for one study does not necessarily mean you won’t qualify for another. In fact, many people who think they are ineligible may still find appropriate trials by reviewing specific requirements carefully and speaking with healthcare providers or trial coordinators.

Understanding what qualifies a person and what doesn’t helps patients explore opportunities with confidence and navigate the clinical trial landscape more effectively.

01/20/2026

Finding the right clinical trial can feel overwhelming, especially during an already difficult journey.

Across Canada, many cancer clinical trials are actively recruiting, but patients and families often struggle to find clear, trustworthy information. Different registries, medical terms, eligibility criteria, and locations can make the search confusing and emotionally exhausting.

Understanding how clinical trials work is the first step. Knowing the trial phase, treatment type, eligibility requirements, and location helps patients make informed decisions and ask the right questions with confidence when speaking to healthcare providers.

With the right tools and guidance, patients can identify trials that align with their diagnosis, treatment goals, and personal circumstances. Access to accurate information empowers patients to explore new options, contribute to research, and feel more in control of their care journey.

A clear, structured approach to finding clinical trials transforms uncertainty into possibility and helps patients move forward with clarity and hope.

Learn how to navigate ongoing cancer clinical trials in Canada and take the next informed step in your care journey.

01/10/2026

Clinical trial recruitment is no longer just slow. It is being redefined.

Traditional recruitment methods often struggle with limited reach, high costs, and long timelines. Many eligible participants are missed simply because data is scattered, screening is manual, and outreach lacks precision. This creates delays that impact research progress and patient access to new treatments.

Artificial intelligence is changing how trials find the right participants. By analyzing large datasets, identifying patterns, and matching eligibility criteria faster, AI helps researchers reach more qualified candidates with greater accuracy. What once took months can now happen in weeks with better outcomes.

AI also supports diversity and inclusion in clinical trials. Smarter algorithms can uncover underrepresented populations, reduce bias in selection, and ensure trials reflect real world patient populations. This leads to stronger data, more reliable results, and more equitable research.

With AI driven recruitment, clinical trials become more efficient, more inclusive, and more patient centered. The future of research is not just faster, it is smarter.

Explore how AI is shaping the next generation of clinical trial recruitment and what it means for the future of research.

12/31/2025

Here's to new horizons and fresh possibilities in 2026!

As we step into another year of innovation and progress, we're grateful for your continued trust and partnership. May this year bring you optimal health outcomes, streamlined workflows, and countless reasons to celebrate.

Happy New Year from the Horizonnt team!

12/24/2025

Wishing you a season wrapped in warmth, joy, and the comfort of loved ones!

As we celebrate this special time, we're thankful for the opportunity to support healthcare excellence alongside you. May your holidays be merry, bright, and filled with peace.

Merry Christmas from all of us at Horizonnt!

12/23/2025

Finding the right clinical trial can feel like searching for a needle in a haystack, especially when you or a loved one is facing a cancer diagnosis. With approximately 900 clinical trials authorized by Health Canada each year, knowing where to start can be overwhelming.

That's why we created this complete guide to help you navigate the clinical trial landscape in Canada. Whether you're newly diagnosed, dealing with recurrent disease, or exploring preventive options, understanding how to find and access clinical trials can open doors to cutting-edge treatments that aren't yet available to the general public.

In this comprehensive resource, you'll discover the top databases and resources for finding cancer clinical trials, including Health Canada's Clinical Trials Database, ClinicalTrials.gov, and how AI-powered platforms like Horizon Trials can simplify your search through personalized matching and real-time notifications.

We break down the four phases of clinical trials, help you understand eligibility criteria, and provide smart search strategies that actually work. You'll also learn how to overcome common barriers like geographic challenges and financial concerns, plus get the essential questions to ask before enrolling.

The guide covers special considerations for different cancer types, from blood cancers to solid tumors and rare cancers. We also share insights on working effectively with your healthcare team and maximizing your clinical trial experience from start to finish.

Remember, clinical trials represent hope not just for your individual situation, but for countless future patients who will benefit from the research you help advance. Every participant contributes to the collective knowledge that drives medical progress forward.

Ready to explore your options? Read the full guide on our website and discover how Horizon Trials can help match you with the right clinical trial based on your unique medical profile. Visit horizonnt.ca to learn more and start your journey toward accessing innovative cancer treatments today.

12/22/2025

Research shows that 64% of patients prefer learning about clinical research studies from their primary care physician. Not from advertisements. Not from online searches. From the doctor they trust.

But here's the problem: Most physicians don't have the time or tools to stay updated on thousands of active clinical trials.

The result?
→ Patients miss life-changing opportunities
→ Clinical trials struggle to find participants
→ Medical breakthroughs take longer to reach the people who need them

Horizon Trial bridges this gap.

We provide primary care physicians and specialists with a powerful tool: instant access to relevant clinical trials and emerging treatments for their patients.

This is healthcare as it should be: collaborative, informed, and hopeful.

Horizon Trial

02/25/2026

02/21/2026

02/18/2026

02/14/2026

02/11/2026

02/08/2026

01/20/2026

01/10/2026

12/31/2025

12/24/2025

12/23/2025

12/22/2025

Address

Telephone

Website

Alerts

Shortcuts

Share

Category